This study investigated the anti‐aging effects of algal Omega3‐DHA in senescence‐accelerated mice (SAM). Male and female SAMP8 mice (3 months old) were divided into a control group and four experimental groups (1× or 2× algal Omega3‐DHA, with/without phospholipids). The mice were orally administered test samples dissolved in corn oil daily for 13 weeks. Aging scores were significantly lower in male mice across all experimental groups and in female mice in the phosphatidylcholine (PC) and phosphatidylserine (PS) ( p < 0.05) groups. Learning and memory improved significantly in all the experimental groups ( p < 0.05). Brain biomarkers of aging, including 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), thiobarbituric acid‐reactive substances (TBARS), protein carbonyl content, and β‐amyloid (Aβ) protein, were significantly reduced, while liver antioxidant enzyme activities, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), were increased in the PC and PS groups ( p < 0.05). Additionally, survival times were extended in both male and female mice compared to controls. No adverse effects were observed in terms of body weight or activity level. In summary, algal Omega3‐DHA supplementation improved cognitive performance, enhanced antioxidant defenses, reduced aging markers, and delayed aging in SAM mice, highlighting its potential as a promising anti‐aging strategy.
Aging is closely associated with oxidative stress, which contributes to functional decline and increased vulnerability to neurodegenerative diseases. Natural antioxidants, such as Chlorella Growth Factor (CGF) and γ-polyglutamic acid (γ-PGA), possess antioxidant and anti-aging properties; however, their combined effects remain unknown. This study investigated the potential synergistic effects of CGF and γ-PGA supplementation in senescence-accelerated mouse-prone 8 (SAMP8) mice, a model characterized by early cognitive decline, locomotor deficits, and elevated oxidative DNA damage. Three-month-old male SAMP8 mice (n = 40) were divided into four groups: control, CGF (49.2 mg/kg BW/day), γ-PGA (20.5 mg/kg BW/day), and combined CGF + γ-PGA (69.7 mg/kg BW/day), and were treated for 13 weeks. Behavioral and physiological assessments included locomotor activity, aging index, and cognitive function (passive and active avoidance tests). Biochemical analysis focused on brain 8-hydroxy-2′-deoxyguanosine (8-OHDG) as a biomarker of oxidative DNA damage. Supplementation with CGF and γ-PGA, particularly in combination, significantly improved locomotor activity, aging scores, and cognitive functions. Notably, the combined treatment yielded the greatest reduction in brain 8-OHDG levels. These findings indicate that CGF and γ-PGA, when administered together, exert enhanced protective effects against functional and molecular aging. In conclusion, long-term supplementation with CGF and γ-PGA protects against aging-related decline in SAMP8 mice. This study highlights the potential of CGF and γ-PGA as safe, natural candidates for the development of functional foods or nutraceuticals aimed at promoting healthy aging and reducing oxidative stress-associated disorders.